IL286399A - History of imidazole as modulators of cxcr4 - Google Patents

History of imidazole as modulators of cxcr4

Info

Publication number
IL286399A
IL286399A IL286399A IL28639921A IL286399A IL 286399 A IL286399 A IL 286399A IL 286399 A IL286399 A IL 286399A IL 28639921 A IL28639921 A IL 28639921A IL 286399 A IL286399 A IL 286399A
Authority
IL
Israel
Prior art keywords
imidazoline derivatives
cxcr4 modulators
cxcr4
modulators
imidazoline
Prior art date
Application number
IL286399A
Other languages
English (en)
Hebrew (he)
Original Assignee
Universit? De Paris
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universit? De Paris, Centre Nat Rech Scient filed Critical Universit? De Paris
Publication of IL286399A publication Critical patent/IL286399A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/429Thiazoles condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/12Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
    • C07D513/14Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL286399A 2019-03-29 2021-09-14 History of imidazole as modulators of cxcr4 IL286399A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP19305409 2019-03-29
PCT/EP2020/058728 WO2020201096A1 (en) 2019-03-29 2020-03-27 Imidazoline derivatives as cxcr4 modulators

Publications (1)

Publication Number Publication Date
IL286399A true IL286399A (en) 2021-10-31

Family

ID=66102603

Family Applications (1)

Application Number Title Priority Date Filing Date
IL286399A IL286399A (en) 2019-03-29 2021-09-14 History of imidazole as modulators of cxcr4

Country Status (12)

Country Link
US (1) US20220144853A1 (https=)
EP (1) EP3947394A1 (https=)
JP (1) JP2022527641A (https=)
KR (1) KR20210146318A (https=)
CN (1) CN113939521A (https=)
AU (1) AU2020255206A1 (https=)
BR (1) BR112021019344A8 (https=)
CA (1) CA3132527A1 (https=)
IL (1) IL286399A (https=)
MX (1) MX2021011599A (https=)
SG (1) SG11202109671WA (https=)
WO (1) WO2020201096A1 (https=)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE565868A (https=) 1957-03-21
DE2348525A1 (de) 1972-09-28 1974-04-11 Searle & Co 2- eckige klammer auf 2-(2-methyl-5nitro-1-imidazolyl)-aethyl eckige klammer zu -2-thio-pseudoharnstoffe
US4205071A (en) 1976-05-14 1980-05-27 Smith Kline & French Laboratories Limited Pharmaceutical compositions having immunosuppressant activity and methods therefor
US4349674A (en) 1978-12-18 1982-09-14 American Home Products Corporation Quinoalinyl esters of carbamimidothioic acids
AR008789A1 (es) * 1996-07-31 2000-02-23 Bayer Corp Piridinas y bifenilos substituidos
US20040254221A1 (en) 2001-09-28 2004-12-16 Toru Yamazaki Novel Nitrogenous Compound and use thereof
GB0324498D0 (en) * 2003-07-21 2003-11-26 Aventis Pharma Inc Heterocyclic compounds as P2X7 ion channel blockers
CA3027296A1 (en) * 2016-06-16 2017-12-21 Centre National De La Recherche Scientifique Compounds useful for decreasing interferon level

Also Published As

Publication number Publication date
WO2020201096A1 (en) 2020-10-08
CN113939521A (zh) 2022-01-14
CA3132527A1 (en) 2020-10-08
MX2021011599A (es) 2021-12-10
BR112021019344A8 (pt) 2022-12-06
AU2020255206A1 (en) 2021-10-14
KR20210146318A (ko) 2021-12-03
BR112021019344A2 (https=) 2021-12-14
EP3947394A1 (en) 2022-02-09
JP2022527641A (ja) 2022-06-02
US20220144853A1 (en) 2022-05-12
SG11202109671WA (en) 2021-10-28

Similar Documents

Publication Publication Date Title
IL292156A (en) Transduced azacils as trmp8 modulators
IL269385A (en) Tooth preparation system for placement of dental veneers
CA185839S (en) Stand
EP3383386B8 (en) Modulators of chemokine receptors
GB201916559D0 (en) Angular response compensation for das vsp
PL3743406T3 (pl) Modulatory tmem16a
IL270620A (en) Pyrimidine history as PGE2 receptor modulators
IL281023A (en) Tetrahydropyridopyrimidine derivatives as AHR modulators
GB2576056B (en) Modulators
HUE070924T2 (hu) 2-Hidroxicikloalkán-1-karbamoil-származékok
IL290815A (en) History of alpha-d-galactopyranoside
PL4077334T3 (pl) Pochodne furoindazolu
IL276007A (en) Modulators for dnm2 expression
EP3778342A4 (en) Gauge-changeable wheelset
GB2585587B (en) Modulators
EP3581572B8 (en) Adenosine a3 receptor modulators
GB201919210D0 (en) Dihydro-cyclopenta-isoquinoline derivatives
CA206454S (en) Seismic sway brace fitting
IL286399A (en) History of imidazole as modulators of cxcr4
HK40064323A (en) Imidazoline derivatives as cxcr4 modulators
ZA202200181B (en) 2-hydroxycycloalkane-1-carbamoyl derivatives
GB202018411D0 (en) Malt-1 modulators i
FI12573U1 (fi) Nosturiteline
GB2585825B (en) Suspending vehicle formulation
GB2582253B (en) Stand